3-Deazaadenosine CAS: 6736-58-9
MF: C11H14N4O4
MW: 266.25
An inhibitor of leukocyte adhesion to TNF-treated endothelial cells.

3-Deazaadenosine (CAS 6736-58-9)

3-Deazaadenosine | CAS 6736-58-9 is rated 5.0 out of 5 by 1.
  • y_2020, m_11, d_25, h_17
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.12
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_216428, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 125ms
  • REVIEWS, PRODUCT
5
1
4
0
3
0
2
0
1
0
Alternate Names: 4-Amino-1-(Beta-D-ribofuranosyl)-1H-imidazo(4,5)-pyridine
Application: 3-Deazaadenosine is an inhibitor of leukocyte adhesion to TNF-treated endothelial cells
CAS Number: 6736-58-9
Purity: ≥98%
Molecular Weight: 266.25
Molecular Formula: C11H14N4O4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).

3-Deazaadenosine is a potent inhibitor of adenosine deaminase, an enzyme that catalyzes the removal of the amine group from adenosine. This compound exhibits antitumor activity against a range of leukemia cell lines. 3-Deazaadenosine is an inhibitor of SAHH.


References

1. Flexner, C.W., et al. Lancet 339, 438, (1992); 2. Jurgensen, C.H., et al. J. Immunol. 144, 653, (1990)

Appearance :
Crystalline powder
Physical State :
Solid
Storage :
Store at 4° C
Boiling Point :
665.69° C at 760 mmHg (Predicted)
Density :
1.91 g/cm3 (Predicted)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
PubChem CID :
23190
MDL Number :
MFCD00153951
SMILES :

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

va risospesa in H2O? non ci sono specifiche

Asked by: ClaCod
Thank you for your question. This is soluble in water at 10 mg/mL (with heating to 60 °C).
Answered by: Tech Service
Date published: 2020-01-16
  • y_2020, m_11, d_24, h_16CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.12
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_1
  • loc_en_US, sid_216428, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 126ms
  • QUESTIONS, PRODUCT
Rated 5 out of 5 by from Lee Lee, SY. et al. (PubMed 21311682) reported that induction of the intrinsic apoptotic pathway by 3-Deazaadenosine is mediated by BAX activation in HL-60 cells. -SCBT Publication Review
Date published: 2015-03-12
  • y_2020, m_11, d_25, h_17
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.12
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_216428, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 7ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.